1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with calpain in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (calpain) | Trials (calpain) | Recent Studies (post-2010) (calpain) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 7,019 | 25 | 2,422 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iizuka, K; Kawaguchi, H; Takano, H; Yasuda, H | 1 |
| Fujii, J; Hiraishi, S; Ishii, H; Kazama, M; Kuboki, M | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and calpain
| Article | Year |
|---|---|
Platelet aggregation induced by platelet-activating factor is suppressed by cystine protease inhibitor.
Topics: Animals; Blood Platelets; Calpain; Cathepsin B; In Vitro Techniques; Indomethacin; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Protease Inhibitors; Rabbits; Serotonin | 1991 |
Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activation.
Topics: Adult; Blood Platelets; Calpain; Cysteine Proteinase Inhibitors; Enzyme Activation; Humans; Inositol Phosphates; Leucine; Phosphatidylinositols; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Serotonin; Thrombin; Type C Phospholipases | 1990 |